- Article metrics
- Last updated: Tue, 23 Apr 2024 15:18:34 Z
A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer
Access & Citations
-
- 2689
- Article Accesses
-
- 0
- Web of Science
-
- 0
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.